Physician

Abdallah Altarshan, MD

According to 2025 Medicare claims, Abdallah Altarshan, MD (NPI: 1174582811) practices endocrinology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is DIABETES & ENDOCRINE CARE LTD (NPI: 1689627168; TIN: 364195318) and primary practice location at 60805-2004. Altarshan is affiliated with the Trinity Health Integrated Care (ACO ID: A3454) and Northwestern Medicine Health Network ACO LLC (ACO ID: A5444), participating under the MSSP model.

Altarshan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 804 traditional Medicare patients, billed 4,839 HCPCS/CPT codes, and received $211,381 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,541 prescription claims across 906 beneficiaries totaling $4,731,465 in drug costs, led by Ozempic (Semaglutide). DME data shows 1,131 claims. Open Payments data shows 118 records totaling $11,884. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,217,936 to $4,731,465. For DME billing, reported payments moved sharply higher in recent years, from $69,589 to $295,865.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,055	6,704	$276,742
2016	970	6,473	$272,757
2017	981	6,152	$268,462
2018	935	6,604	$269,841
2019	1,012	6,601	$274,012
2020	973	5,781	$257,553
2021	941	5,915	$268,616
2022	881	5,487	$233,520
2023	816	5,275	$231,541
2024	804	4,839	$211,381

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	503	5,878	$1,217,936
2016	480	5,812	$1,266,686
2017	536	6,341	$1,529,069
2018	642	6,868	$1,911,604
2019	687	7,237	$2,514,053
2020	757	7,369	$2,877,043
2021	787	7,107	$3,137,491
2022	788	7,092	$3,747,216
2023	848	8,203	$5,720,634
2024	906	8,541	$4,731,465

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	551	1,548	$93,425
2016	587	1,632	$103,997
2017	499	1,218	$132,084
2018	473	1,269	$172,389
2019	521	1,549	$241,740
2020	496	1,712	$286,726
2021	464	1,807	$327,117
2022	382	1,795	$323,570
2023	331	1,682	$340,663
2024	315	1,131	$318,393

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	212	462	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	409	704	$65
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	204	885	$64
83037	Hemoglobin a1c level, by device for home use	348	812	$9
82962	Blood glucose (sugar) test performed by hand-held instrument	370	908	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	1,047	43,297	$1,428,253
Korlym	Mifepristone	17	510	$665,609
Jardiance	Empagliflozin	446	21,247	$413,249
Omnipod Dash Pods (Gen 4)	Insulin Pump Cart,cont Inf,bt	187	7,120	$197,917
Trulicity	Dulaglutide	172	5,668	$196,277

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	136	699	$252,734
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	14	48	$27,030
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	22	61	$14,808
E0784	External ambulatory infusion pump, insulin	Y	N/R	31	$10,231
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	25	25	$5,644

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	118	$11,884	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdallah Altarshan, MD?

Tedicare shows public-source Medicare data for Abdallah Altarshan, MD (NPI 1174582811), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdallah Altarshan, MD have ACO affiliation data?

Abdallah Altarshan, MD is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454) and Northwestern Medicine Health Network ACO LLC (MSSP, ACO ID A5444).

What billing organization is linked to Abdallah Altarshan, MD?

Abdallah Altarshan, MD is linked to DIABETES & ENDOCRINE CARE LTD (billing NPI 1689627168) in the available physician profile data.

Does Abdallah Altarshan, MD have Open Payments data?

Abdallah Altarshan, MD has 118 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.